An	DT
ex	FW
vivo	FW
model	NN
to	TO
induce	VB
early	JJ
fibrosis-like	JJ
changes	NNS
in	IN
human	JJ
precision-cut	JJ
lung	NN
slices	NNS
.	.

IPF	NN
is	VBZ
a	DT
devastating	JJ
chronic	JJ
interstitial	JJ
lung	NN
disease	NN
(	(
ILD	NN
)	)
characterized	VBN
by	IN
lung	NN
tissue	NN
scarring	NN
and	CC
high	JJ
morbidity	NN
.	.

Lung	NN
epithelial	JJ
injury	NN
,	,
myofibroblast	NN
activation	NN
,	,
and	CC
deranged	JJ
repair	NN
are	VBP
believed	VBN
to	TO
be	VB
key	JJ
processes	NNS
involved	VBN
in	IN
disease	NN
onset	NN
and	CC
progression	NN
but	CC
the	DT
exact	JJ
molecular	JJ
mechanisms	NNS
behind	IN
IPF	NN
remain	VBP
unclear	JJ
.	.

Several	JJ
drugs	NNS
have	VBP
been	VBN
shown	VBN
to	TO
slow	VB
disease	NN
progression	NN
,	,
but	CC
treatments	NNS
which	WDT
halt	VBP
or	CC
reverse	VBP
IPF	NNP
progression	NN
have	VBP
not	RB
been	VBN
identified	VBN
.	.

Ex	FW
vivo	FW
models	NNS
of	IN
human	JJ
lung	NN
have	VBP
been	VBN
proposed	VBN
for	IN
drug	NN
discovery	NN
,	,
one	CD
of	IN
which	WDT
is	VBZ
precision-cut	JJ
lung	NN
slices	NNS
(	(
PCLS	NNS
)	)
.	.

Although	IN
PCLS	NN
production	NN
from	IN
IPF	NN
explants	NNS
is	VBZ
possible	JJ
,	,
IPF	NN
explants	NNS
are	VBP
rare	JJ
and	CC
typically	RB
represent	VBP
end-stage	JJ
disease	NN
.	.

Here	RB
we	PRP
present	VBP
a	DT
novel	JJ
model	NN
of	IN
early	JJ
fibrosis-like	JJ
changes	NNS
in	IN
human	JJ
PCLS	NN
derived	VBN
from	IN
patients	NNS
without	IN
ILD/IPF	NN
using	VBG
a	DT
combination	NN
of	IN
profibrotic	JJ
growth	NN
factors	NNS
and	CC
signaling	VBG
molecules	NNS
.	.

Fibrotic-like	JJ
changes	NNS
of	IN
PCLS	NNS
were	VBD
qualitatively	RB
analyzed	VBN
by	IN
histology	NN
and	CC
immunofluorescence	NN
and	CC
quantitatively	RB
by	IN
WST1	NN
,	,
RT-qPCR	NN
,	,
WB	NNP
,	,
and	CC
ELISA	NN
.	.

PCLS	NN
remained	VBD
viable	JJ
after	IN
5	CD
days	NNS
of	IN
treatment	NN
and	CC
fibrotic	JJ
gene	NN
expression	NN
(	(
FN1	NN
,	,
SERPINE1	NN
,	,
COL1A1	NN
,	,
CTGF	NN
,	,
MMP7	NN
and	CC
ACTA2	NN
)	)
increased	VBD
as	RB
early	JJ
as	IN
24h	NN
of	IN
treatment	NN
,	,
with	IN
increases	NNS
in	IN
protein	NN
levels	NNS
at	IN
48	CD
hours	NNS
and	CC
increased	VBD
deposition	NN
of	IN
extracellular	JJ
matrix	NN
.	.

Alveolar	JJ
epithelium	NN
reprogramming	NN
was	VBD
evident	JJ
by	IN
decreases	NNS
in	IN
SFTPC	NNP
and	CC
loss	NN
of	IN
HOPX	NNP
In	IN
summary	NN
,	,
using	VBG
human-derived	JJ
PCLS	NNS
from	IN
patients	NNS
without	IN
ILD/IPF	NN
,	,
we	PRP
established	VBD
a	DT
novel	JJ
ex	FW
vivo	FW
model	NN
which	WDT
displays	VBZ
characteristics	NNS
of	IN
early	JJ
fibrosis	NN
and	CC
could	MD
be	VB
used	VBN
to	TO
evaluate	VB
novel	JJ
therapies	NNS
and	CC
study	NN
early-stage	JJ
IPF	NN
pathomechanisms	NNS
.	.

